Dem Biopharma

Developer of immunotherapeutics for the treatment of cancer

placeCambridge, Massachusetts, United States calendar_todayFounded 2022 groups37 employees language dembiopharma.com

Social engagement

Social engagement: 2K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include Alta Partners, Longwood Fund.

Investor typeCountShare
Venture capital556%
Private equity111%
Other / undisclosed333%

Recent activity

6 Jan 2026
Event
2026 ASCO Gastrointestinal Cancers Symposium
Coming soon